THE FUTURE OF NON-ADDICTIVE PAIN MANAGEMENT

Vivera Pharmaceuticals, Inc.

Application Filed: 2018-10-23
Trademark Application Details
Trademark Logo THE FUTURE OF NON-ADDICTIVE PAIN MANAGEMENT

Mark For: THE FUTURE OF NON-ADDICTIVE PAIN MANAGEMENT™ trademark registration is intended to cover the categories of drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of orodispersable tablets and/or sublingual tablets that facilitate the delivery of pharmaceutical preparations; Pain relief medication; Pharmaceutical preparations for the treatment and prevention of chronic pain; Pharmaceutical preparations for the treatment of the cardiovascular system, the circulatory system, the digestive system, the excretory system, the endocrine system, the integumentary system, the exocrine system, the lymphatic system, the immune system, the muscular system, the nervous system, the renal system, the urinary system, the reproductive system, and/or the skeletal system; Pharmaceutical preparations for non-addictive pain management; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Chemical preparations for pharmaceutical or medical purposes, namely, for non-addictive pain management. [all]

Status

2021-05-26 UTC
LIVE APPLICATION Under Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and that this application has been assigned to an examiner.


Research OneLook Acronym Finder
Serial Number88165746
Mark Literal ElementsTHE FUTURE OF NON-ADDICTIVE PAIN MANAGEMENT
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTRADEMARK. SERVICE MARK
RegisterPRINCIPAL
Current LocationINTENT TO USE SECTION 2019-04-23
Basis1(b)
Class StatusACTIVE
Primary US Classes
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseNo
Intent To UseYes
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameMarc Hankin
Law Office AssignedL80
Employee NameBUSH, KAREN K

Timeline

2018-10-23Application Filed
2019-01-18Location: PUBLICATION AND ISSUE SECTION
2019-01-18Status: Live/Pending
2019-02-06Transaction Date
2019-02-26Published
2019-02-26Published for Opposition
2019-04-23Location: INTENT TO USE SECTION
2021-04-23Status: A fourth request for extension of time to file a Statement of Use has been granted.

Trademark Parties (Applicants & Owners)

Party: Vivera Pharmaceuticals, Inc.
Address4533 MacArthur Blvd., #5049 Newport Beach, CALIFORNIA UNITED STATES 92660
Legal Entity TypeCorporation
Legal Entity StateNEVADA

Documents

DrawingJPEG2018-10-23
TEAS Plus New ApplicationMULTI2018-10-23
XSearch Search SummaryXML2019-01-16
TRAM Snapshot of App at Pub for OppostnMULTI2019-01-18
Notice of PublicationXML2019-02-06
Notification Of Notice of PublicationXML2019-02-06
OG Publication ConfirmationAPPLICATION/XML2019-02-26
TEAS Rev, App and/or COA of Atty/Dom.RepXML2019-04-22
Notice of AllowanceXML2019-04-23
Extension of Time to File SOUXML2019-10-16
ITU Extension ApprovalAPPLICATION/XML2019-10-18
ITU Unit ActionMULTI2019-10-18
TEAS Rev, App and/or COA of Atty/Dom.RepMULTI2019-11-13
Notice of AbandonmentAPPLICATION/XML2020-06-08
ITU Unit ActionMULTI2020-06-09
TEAS Petition to Revive SOUMULTI2020-08-10
Notice Of Revive ApplicationAPPLICATION/XML2020-08-11
ITU Extension ApprovalXML2020-10-06
ITU Unit ActionAPPLICATION/XML,IMAGE/JPEG2020-10-06
TEAS Withdrawal of AttorneyXML2020-10-08
Notice of AbandonmentAPPLICATION/XML2020-11-23
ITU Unit ActionMULTI2020-11-24
Notice Of Revive ApplicationXML2020-12-11
TEAS Petition to Revive SOUMULTI2020-12-11
ITU Extension ApprovalAPPLICATION/XML2020-12-19
ITU Unit ActionAPPLICATION/XML,IMAGE/JPEG2020-12-19
Extension of Time to File SOUAPPLICATION/XML2021-04-23
ITU Extension ApprovalAPPLICATION/XML2021-04-27
ITU Unit ActionAPPLICATION/XML,IMAGE/JPEG2021-04-27

Attorney of Record

MARC HANKIN
HANKIN PATENT LAW, APC
12400 WILSHIRE BOULEVARD, SUITE 1265
LOS ANGELES, CA 90025

Good, Services, and Codes


IC 005. US 006 018 044 046 051 052. G & S: Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of orodispersable tablets and/or sublingual tablets that facilitate the delivery of pharmaceutical preparations; Pain relief medication; Pharmaceutical preparations for the treatment and prevention of chronic pain; Pharmaceutical preparations for the treatment of the cardiovascular system, the circulatory system, the digestive system, the excretory system, the endocrine system, the integumentary system, the exocrine system, the lymphatic system, the immune system, the muscular system, the nervous system, the renal system, the urinary system, the reproductive system, and/or the skeletal system; Pharmaceutical preparations for non-addictive pain management; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Chemical preparations for pharmaceutical or medical purposes, namely, for non-addictive pain management
IC 044. US 100 101. G & S: Medical and pharmaceutical consultation; Pharmaceutical advice; Dispensing of pharmaceuticals; Medical services, namely, non-addictive treatment of chronic pain; Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals

International Codes:5
U.S. Codes:006,018,044,046,051,052
International Codes:44
U.S. Codes:100,101
Type CodeType
GS0051Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of orodispersable tablets and/or sublingual tablets that facilitate the delivery of pharmaceutical preparations; Pain relief medication; Pharmaceutical preparations for the treatment and prevention of chronic pain; Pharmaceutical preparations for the treatment of the cardiovascular system, the circulatory system, the digestive system, the excretory system, the endocrine system, the integumentary system, the exocrine system, the lymphatic system, the immune system, the muscular system, the nervous system, the renal system, the urinary system, the reproductive system, and/or the skeletal system; Pharmaceutical preparations for non-addictive pain management; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Chemical preparations for pharmaceutical or medical purposes, namely, for non-addictive pain management
GS0051Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of orodispersable tablets and/or sublingual tablets that facilitate the delivery of pharmaceutical preparations; Pain relief medication; Pharmaceutical preparations for the treatment and prevention of chronic pain; Pharmaceutical preparations for the treatment of the cardiovascular system, the circulatory system, the digestive system, the excretory system, the endocrine system, the integumentary system, the exocrine system, the lymphatic system, the immune system, the muscular system, the nervous system, the renal system, the urinary system, the reproductive system, and/or the skeletal system; Pharmaceutical preparations for non-addictive pain management; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Chemical preparations for pharmaceutical or medical purposes, namely, for non-addictive pain management; none of the foregoing items comprised of Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) content of more than 0.3 percent on a dry weight basis and none of which are comprised of cannabidiol (CBD)

Trademark Filing History

DescriptionDateProceeding Number
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2021-04-27
TEAS EXTENSION RECEIVED2021-04-23
EXTENSION 4 GRANTED2021-04-2398765
EXTENSION 4 FILED2021-04-2398765
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2020-12-19
EXTENSION 3 GRANTED2020-12-1876538
TEAS PETITION TO REVIVE RECEIVED2020-12-11
PETITION TO REVIVE-GRANTED2020-12-1188889
NOTICE OF REVIVAL - E-MAILED2020-12-11
EXTENSION RECEIVED WITH TEAS PETITION2020-12-11
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED2020-11-23
ABANDONMENT - NO USE STATEMENT FILED2020-11-2399999
EXTENSION 3 FILED2020-10-2376538
WITHDRAWAL OF ATTORNEY GRANTED2020-10-08
TEAS WITHDRAWAL OF ATTORNEY RECEIVED2020-10-08
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2020-10-06
EXTENSION 2 GRANTED2020-10-0576538
CASE ASSIGNED TO INTENT TO USE PARALEGAL2020-10-0576538
NOTICE OF REVIVAL - E-MAILED2020-08-11
TEAS PETITION TO REVIVE RECEIVED2020-08-10
PETITION TO REVIVE-GRANTED2020-08-1088889
EXTENSION RECEIVED WITH TEAS PETITION2020-08-10
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED2020-06-08
ABANDONMENT - NO USE STATEMENT FILED2020-06-0899999
EXTENSION 2 FILED2020-04-2376538
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED2019-11-13
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED2019-11-13
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2019-10-18
TEAS EXTENSION RECEIVED2019-10-16
EXTENSION 1 GRANTED2019-10-1698765
EXTENSION 1 FILED2019-10-1698765
NOA E-MAILED - SOU REQUIRED FROM APPLICANT2019-04-23
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED2019-04-22
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED2019-04-22
PUBLISHED FOR OPPOSITION2019-02-26
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2019-02-26
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2019-02-06
APPROVED FOR PUB - PRINCIPAL REGISTER2019-01-17
ASSIGNED TO EXAMINER2019-01-1567516
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2018-11-04
NEW APPLICATION ENTERED IN TRAM2018-10-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed